The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
OTC Obesity - France
US$ 990.00
The main story in OTC obesity was the entrance of Alli by GlaxoSmithKline in 2009. According to trade press, ... resulted in free advertising for the GlaxoSmithKline brand. Euromonitor International's OTC Obesity Products in France report offers a comprehensive guide to the size and shape ...
April 2010
49 pages
OTC Obesity - Poland
US$ 990.00
... the first year that OTC obesity gained a presence in Poland. In April 2009 GlaxoSmithKline Pharmaceuticals SA launched the first orlistat-based OTC obesity product under the Alli brand name. 2009 value sales reached more than PLN4 million. Euromonitor International's OTC Obesity Products in Poland ...
April 2010
35 pages
OTC Obesity - Spain
US$ 990.00
... within Spain. This is the only OTC obesity product available in Spain. In its first year sales of Alli reached a value of EUR9 million. Euromonitor International's OTC Obesity Products in Spain ...
April 2010
39 pages
Global Pain Relieving Drug Market Analysis 2010-2025
US$ 2,325.00
... market with high, growing demand worldwide? In 2009, the global pain relieving drug market generated revenues over $50bn. From 2010, that ... and secondary research. This report provides unique sales forecasts, market share analyses, discussions of R&D pipeline developments and analyses of commercial drivers ...
April 2010
150 pages
BRIC Diabetes Drugs Market
US$ 5,650.00
... market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come. Market Estimates and Forecasts The report categorizes the BRIC Diabetes Drugs market as follows: • Injectables Market ...
April 2010
118 pages
NRT Smoking Cessation Aids - Denmark
US$ 900.00
Growing demand boosted NRT smoking cessation aids sales as Danish smokers are increasingly interested in quitting their habit. The trend has accelerated since the nationwide public smoking ban was int...
April 2010
32 pages
OTC Obesity - Denmark
US$ 990.00
... category was switched to OTC status in May 2009. There is much public focus on the dangers and growing problem of obesity in Denmark. Consumers therefore showed ... , after only seven months on the market. Euromonitor International's OTC Obesity Products in Denmark report offers a comprehensive guide to the size and shape of the ...
April 2010
29 pages
Cardiovascular Drugs: Market Research Report
US$ 4,450.00
... report analyzes the worldwide markets for Cardiovascular Drugs in US$ Million. Cardiovascular diseases can be prevented or treated using different classes of drugs. Broadly, the ... 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 115 companies including many key and ...
April 2010
1058 pages
Erectile Dysfunction Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Erectile Dysfunction Drugs in US$ Million. The report provides separate comprehensive analytics for US, Canada, ... 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 26 companies including many key and niche ...
April 2010
391 pages
Petrolatum: Market Research Report
US$ 3,450.00
This report analyzes the worldwide markets for Petrolatum in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe, ... 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 53 companies including Anika Laboratories, Inc., Grand ...
April 2010
163 pages
HIV Drugs: Market Research Report
US$ 4,450.00
This report analyzes the Worldwide markets for HIV Drugs in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe ... & Co., Inc., Pfizer, Inc., Tibotec BVBA, ViiV Healthcare, and VIRxSYS Corp. Market data and analytics are derived from primary and secondary research. ...
April 2010
484 pages
Liver Cancer Drugs: Market Research Report
US$ 3,950.00
This report analyzes the Global market for Liver Cancer Drugs in US$ Million. Annual estimates and forecasts are provided for the period 2007 ... , Inc., Pfizer Inc., Progen Pharmaceuticals Ltd., and Teva Pharmaceutical Industries Ltd. Market data and analytics are derived from primary and secondary research. ...
April 2010
506 pages
Pancreatic Cancer Drugs: Market Research Report
US$ 3,450.00
This report analyzes the Global market for Pancreatic Cancer Drugs in US$ Million. Annual forecasts are provided for the period 2006 through 2015 ... and Company, F. Hoffmann-La Roche Ltd.., Genentech Inc., and OSI Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. ...
April 2010
405 pages
Neurodegenerative Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Neurodegenerative Drugs in US$ Million by the following disease types: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Other Neurodegenerative Diseases. The report provides separate comprehensive analytics for the ...
April 2010
1108 pages
Antibacterial Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Antibacterial Drugs in US$ Million by the following drug classes: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, and Other Antibacterial Drugs. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. ...
April 2010
719 pages
Pulmonary Drug Delivery Technologies: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in US$ Million by the following Product Segments: Metered Dose Inhalers ( ... through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 61 companies including many key and niche players ...
April 2010
599 pages
Anemia Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Anemia Drugs in US$ Million by the following segments: Short Acting ESAs (Erythropoiesis Stimulating Agents), and ... , Inc., ProMetic Life Sciences, Inc., and Takeda Pharmaceutical Company Limited. Market data and analytics are derived from primary and secondary ...
April 2010
490 pages
Psoriasis Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Psoriasis Drugs in US$ Million by the following Drug Administration Routes - Systemic Drugs, and Topical Drugs ... Ltd., Valeant Pharmaceuticals International, Vertex Pharmaceuticals, Inc., and Wyeth. Market data and analytics are derived from primary and secondary ...
April 2010
568 pages
Analgesics - Philippines
US$ 990.00
... ibuprofen, were notable beneficiaries of this trend. Euromonitor International's Analgesics Products in Philippines report offers a comprehensive guide to the size and shape of the ... how the market is set to change. Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic Data coverage: market sizes (historic and forecasts), company ...
March 2010
39 pages
Analgesics - Singapore
US$ 990.00
... to achieve a perceived more effective and faster cure. Euromonitor International's Analgesics Products in Singapore report offers a comprehensive guide to the size and shape ... books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network ...
March 2010
36 pages
Calming and Sleeping - Singapore
US$ 990.00
... and other sleeping problems due to the stressful lifestyles. Hence, consumers turned to calming and sleeping products to aid sleep. Euromonitor International's Calming and Sleeping Products in Singapore report ... books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network ...
March 2010
33 pages
Cough, Cold and Allergy (Hay Fever) Remedies - Philippines
US$ 990.00
... , demand for cough, cold and allergy (hay fever) remedies products was boosted by erratic weather patterns that caused several typhoons to hit the Philippines. In addition ... in the wake of the economic downturn. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies Products in Philippines report offers a comprehensive guide to the size and ...
March 2010
40 pages
Cough, Cold and Allergy (hay Fever) Remedies - Singapore
US$ 990.00
... was relatively harmless, consumers reverted... Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies Products in Singapore report offers a comprehensive guide to the size and ... . Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery ...
March 2010
38 pages
Digestive Remedies - Algeria
US$ 990.00
Digestive remedies is one of the largest categories in value terms in consumer healthcare in Algeria, ranking second, albeit lagging far behind, only to analgesics. Sales of digestive remedies continued to be driven by a heavy diet and poor eating habits. Euromonitor International's Digestive Remedies Products in Algeria report offers a comprehensive guide ...
March 2010
25 pages
Digestive Remedies - Philippines
US$ 990.00
... they become ill while away from home. Euromonitor International's Digestive Remedies Products in Philippines report offers a comprehensive guide to the size and shape ... . Product coverage: Child-Specific Digestive Remedies, Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies Data coverage: market sizes (historic ...
March 2010
38 pages
Digestive Remedies - Singapore
US$ 990.00
... , featuring firemen spraying antacids all over a person’s... Euromonitor International's Digestive Remedies Products in Singapore report offers a comprehensive guide to the size and shape ... . Product coverage: Child-Specific Digestive Remedies, Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies Data coverage: market sizes (historic ...
March 2010
36 pages
Emergency Contraception - Greece
US$ 990.00
... . Despite the legal framework behind its status, emergency contraception is available under-the-counter in Greece. The prescription-bound status of the products however ... promotions made are directly linked with doctors... Euromonitor International's Emergency Contraception Products in Greece report offers a comprehensive guide to the size and shape ...
March 2010
33 pages
NRT Smoking Cessation Aids - Algeria
US$ 990.00
... smoked. In 2008, it was also estimated that 15,000 Algerians die every year from smoking-related diseases. Further studies also indicate that smoking ... , despite this high smoking prevalence and dramatic forecasts, NRT smoking cessation aids sales remained negligible in Algeria in 2009. One of the... Euromonitor International's NRT Smoking Cessation Aids Products in Algeria report offers ...
March 2010
21 pages
NRT Smoking Cessation Aids - Philippines
US$ 990.00
... bans smoking in public areas, NRT smoking cessation aids remained a niche sector in the Philippines in 2009. This was partly due to the high price of non-prescription NRT smoking cessation aids products ... to quit smoking. Furthermore, smoking is very fashionable among the younger generation of Filipinos. As a result, the number of smokers... Euromonitor International's NRT Smoking Cessation Aids Products in Philippines report offers ...
March 2010
36 pages
NRT Smoking Cessation Aids - Singapore
US$ 990.00
... 1st January 2009, the National Environment Agency (NEA) extended Singapore’s smoking ban to all lift lobbies, entrances or exits of buildings, playgrounds, indoor ... represented Singapore Duty-Paid Cigarettes. Due to the inconvenience of finding somewhere suitable to smoke and the higher risk of purchasing... Euromonitor International's NRT Smoking Cessation Aids Products in Singapore ...
March 2010
34 pages
OTC Obesity - Greece
US$ 990.00
... line with EU regulations, products in OTC obesity were not available in Greece in 2008. However, in October 2008, the European Medicines Agency (EMEA) ... ” is characterised as GlaxoSmithKline’s “de-tuned” version of the popular... Euromonitor International's OTC Obesity Products in Greece report offers a comprehensive guide to the size and shape of the ...
March 2010
33 pages
OTC Obesity - Philippines
US$ 990.00
... by 10%. During the first half of the review period, demand for OTC obesity products grew strongly as many Filipinos, influenced by the mass media ... advent of OTC obesity products provided a safer and cheaper alternative to liposuction and other weight loss treatments... Euromonitor International's OTC Obesity Products in Philippines report offers ...
March 2010
34 pages
OTC Obesity - Portugal
US$ 990.00
Value sales of OTC obesity in Portugal, comprised exclusively of the Alli brand, represented EUR2 million in 2009. In ... those which benefit from word-of-mouth recommendations. Euromonitor International's OTC Obesity Products in Portugal report offers a comprehensive guide to the size and shape ...
March 2010
32 pages
OTC Obesity - Singapore
US$ 990.00
... likely to have a spillover effect on OTC obesity’s performance, which limited its overall growth. Euromonitor International's OTC Obesity Products in Singapore report offers a comprehensive guide to the ... books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network ...
March 2010
32 pages
OTC Obesity - USA
US$ 990.00
Sales of OTC obesity treatments declined by 2% in 2009. The switch of Alli, the first FDA ... in 37 US states in 2007 over the previous year. While overall US obesity rates appear to be stabilising, 34% of US adults aged 20 or above were obese in 2006. Euromonitor International's OTC Obesity Products in USA ...
March 2010
47 pages
Branded vs Generics Drugs in Latin America
US$ 395.00
On every border, across every frontier of Latin America, a revolution is underway. Prefaced by the ground-breaking Hatch-Waxman Act of 1984, the war for market share between generic and branded pharma...
February 2010
52 pages
Anti-Migraine Drugs: Market Research Report
US$ 3,950.00
This report analyzes the US And European markets for Anti-Migraine Drugs in US$ Million. Annual forecasts are provided for the period 2006 ... AstraZeneca Plc, Bayer AG, Ethypharm S.A., GlaxoSmithKline Plc, Meda AB, Novartis AG, and Novartis AG. Market data and analytics are derived from primary and secondary ...
February 2010
580 pages
Cold, Cough, And Sore Throat Remedies: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Cold, Cough, And Sore Throat Remedies in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for ...
February 2010
873 pages
Allergy Drugs: Market Research Report
US$ 3,950.00
... report analyzes the US Market for Allergy Drugs in US$ Million by the following types - Prescription Antihistamines, Prescription Corticosteroids, and OTC Allergy Drugs. Annual ... Healthcare, Inc., Schering-Plough Corp, Sepracor, Inc., and Vicks. Market data and analytics are derived from primary and secondary ...
February 2010
583 pages
Epigenetics: Market Research Report
US$ 4,500.00
This report analyzes the Global market for Epigenetics in US$ Million by the following Application Areas: Drug Discovery, Diagnostics, and Others. Annual ... MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion Genomics. Market data and analytics are derived from primary and secondary ...
February 2010
361 pages
Anti-Hypertensive Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Anti-Hypertensive Drugs in US$ Million. The report provides separate comprehensive analytics for US, Europe and ... Company Limited, Teva Pharmaceutical Industries Limited, and The Medicines Company. Market data and analytics are derived from primary and secondary ...
February 2010
893 pages
Research Report of China Vitamin Complex Market
US$ 400.00
Vitamin complex enjoys a global market of tens of billions of dollars. For China, a nation who makes up one-fifth of the world’s population, the application amount of vitamin complex remains only one-...
December 2009
11 pages
European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
US$ 7,495.00
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: ...
October 2009
102 pages
OTC Obesity - Venezuela
US$ 990.00
... were no OTC obesity products available in Venezuela over the review period, although the UTC market does exist. The best known obesity medicine is Xenical ... to avoid being overweight. Reductil was also available. Euromonitor International's OTC obesity in Venezuela report offers a comprehensive guide to the size and shape of the ...
August 2009
28 pages
OTC Triptans - Venezuela
US$ 990.00
OTC triptans were not available in the Venezuelan market and it is unlikely that they will be introduced as OTC in the future. Euromonitor International's OTC triptans in Venezuela report offers ... data. Why buy this report? Get a detailed picture of the OTC triptans market; Pinpoint growth sectors and identify factors driving change ...
August 2009
28 pages
Drug Delivery Markets: Oral Delivery
US$ 2,995.00
Since our last edition of this report in 2007, The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical compan...
July 2009
130 pages
